InsidersTradesSigma
Track the Cohance Lifesciences stock price and the full directors' dealings record of the company, a publicly traded company based in India. Shares are quoted on the IN market, under the supervision of SEBI (PIT + SAST). Market capitalisation: €177bn. The latest transaction was filed on 25 August 2026 (Disposal). Among the most active insiders: Jusmiral Holdings Limited. The full history is openly available.
Analysts rate Cohance Lifesciences Hold (neutral), based on 9 analysts. Average price target: ₹508.33.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Cohance Lifesciences is a company focused on developing innovative solutions for the healthcare sector in the life sciences field. It is listed on the XBOM.